ArticlePharmacoEconomics2008

Costs and effects of secondary prevention with perindopril in stable coronary heart disease in Poland: an analysis of the EUROPA study including 1251 Polish patients.

W Ken Redekop et al.PubMed ↗Publisher ↗

No numbers read from the abstract.